๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
Addus HomeCare Corporation (ADUS)
NASDAQ: ADUS ยท Real-Time Price ยท USD
122.50
+1.43 (1.18%)
Nov 20, 2026, 4:00 PM EST - Market closed
โ† View all transcripts

2026 Stephens Annual Investment Conference | NASH2026

Nov 17, 2026

Summary

2026 performance was strong across all care segments, with no observed impact from OB3 work requirements. Priorities for 2027 include closing AccentCare, adding clinical services, improving caregiver utilization and advancing data-enabled care coordination.

Raj Kumar
Healthcare Services Analyst, Stephens

Looks like we are at the top of the hour, so we can get started. Welcome everyone to day one of the Stephens 2026 Annual Investment Conference, live and in person from Nashville. I am Raj Kumar, Healthcare Services Analyst at Stephens. To start off our healthcare services fireside chats, we have Addus HomeCare, a leading provider of home-based care and support services, focusing on providing personal care, hospice, and home health services. Joining us here today from Addus are Dirk Allison, Chairman and CEO, and Brian Poff, EVP and CFO. I want to thank you both for joining us here at our conference today, and I think we will just jump right into Q&A, if that sounds good.

Awesome. Yeah, maybe just to kick off the conversation, 2026 has kind of been a good year, I think, across all three lines of businesses. As we kind of think about maybe going through a year in review, maybe kind of walk us through how 2026 has played out relative to kind of your internal expectations.

Dirk Allison
Chairman and CEO, Addus HomeCare

Sure. We think 2026 has been a good year for us, and like you mentioned, all three levels of care. It started out with a little bit of a cloud over the industry. I think with OB3 out there, people not understanding exactly how the Medicaid cuts were going to affect our business. We internally felt like, if you look at the work requirements, you look at the taxes that they were going to change, we did not feel like it would be a direct impact on our company. In fact, in the case of work requirements, we wondered would it be somewhat of a tailwind on hiring.

So that was something I think the industry had to deal with. I think what we have seen as we have gone through the year, our performance financially has been pretty strong. We got our home health headed back in the right direction. PCS has done well. We have had hourly growth. I think what has really reflected itself, we have not seen big negative impacts as it relates to OB3. We had one state out in the West, Montana, that has actually already put in work requirements.

So it was a little bit of a test for us to see how would it affect the company. Really, what we would say is it has had no effect. We have not seen any decrease on the number of patients we have been able to bring into the system. The state has been able to handle the work requirements appropriately. On the other side, maybe it is still early, but 90- 120 days in, we have not seen an influx of people looking to go to work either. So, I would say 2026 has been a good year.

We started the year believing there were going to be acquisition opportunities out there, especially in the PCS world this year. We were able to announce during the year, obviously, the AccentCare transaction, which we should close in the first quarter. So again, another opportunity that grows our business by about $280 million a year in revenue, which is another important aspect. So, pretty excited. We look forward to 2027 also. We think it's going to be another good year, not only from the standpoint of continued incremental improvements as we've seen, but also we think there'll be some acquisition opportunities we can take advantage of.

Raj Kumar
Healthcare Services Analyst, Stephens

Got it. And maybe kind of table setting broadly for 2027. I guess kind of what are some of the puts and takes to keep in mind? I know you've talked about clinical acquisitions, but CMS extended the kind of moratorium, although there's some nuances there that provide some relief for existing licenses. Maybe just kind of talk about 2027 in that context and kind of how you see the M&A landscape in terms of you still being kind of able to execute on your kind of clinical acquisition targets or kind of what's in the pipeline as you kind of think about expansion in that business.

Dirk Allison
Chairman and CEO, Addus HomeCare

Sure. I think one of the exciting things is we've already got one of the big ones done. We should close AccentCare February is what we're hoping for. We've already passed antitrust, so we're just waiting on the additional regulatory approvals we need. We're in the process right now of meeting with their team. We've been very open developing the transition plan. That really allows us hopefully now to start looking at that next big deal out there. We're aware of two or three things that should be coming up in 2027. One of the things that we've done as a company, Brian has done a very good job as our Chief Financial Officer, is keeping our balance sheet clean. When we close on AccentCare, we will still only be levered about one times EBITDA, so still have debt capacity to do other larger transactions.

We've already started talking to some folks, but as the processes get more official, we see opportunities to do some things. There's one or two PCS transactions we know are going to be out there, but as we talked about on the call, one of the things we'd like to do also is bring some more clinical services to the company. If you go back three or four years ago, we ran 25% or so of the business was clinical services with Gentiva closing and then followed by AccentCare, we're going to be down to about 18% on the clinical side. We'd like to get that up 25%-30%. So, we'll continue to look at personal care also. That's our main business, but we believe supplementing that with clinical services in 2027 is a real opportunity we're looking forward to.

Raj Kumar
Healthcare Services Analyst, Stephens

Got it. As we kind of think about the midterms, just kind of, I'm going to be asking this of all of our companies here, but how do you kind of see the midterms in terms of the benefits to your business kind of broadly? Then maybe are you seeing any potential concerns from a policy perspective as we kind of see what the kind of Dems have kind of been wanting to do from a provider standpoint?

Dirk Allison
Chairman and CEO, Addus HomeCare

Our biggest challenge over the last couple years has been the federal government coming out, like with OB3 and taking Medicaid money away. It appears with the Democratic majority in the House and the Senate, that probably has gone away. They're talking about trying to do things such as eliminate or at least defer work requirements. We saw that come out this week where we got a six-month deferral. I think from a standpoint of the regulatory environment, we're in a little bit better position today than we might have been before. Democratic leadership has tended to put more dollars into Medicaid and the lower income benefits that we operate in for the majority of our business, so we're pretty excited about that. In most of our states, New Mexico, our three top large states, New Mexico and Illinois already had Democratic leadership.

Not much should change there with the exception of we should hopefully see continued rate increases. Maybe Illinois, we skipped a year. Hopefully we'll be back to getting that rate increase next year. The interesting one's Texas.

Raj Kumar
Healthcare Services Analyst, Stephens

Yeah.

Dirk Allison
Chairman and CEO, Addus HomeCare

We went from a red state, from a state standpoint, to a blue state in one election, for the first time in 30 years. The Republican leadership before had shown the last two biennial sessions that they've given us rate increases. We were already in the process with our lobbyists and our state association of talking to them about the next session starting in January of 2027 about getting a rate increase. Now it's going to be interesting to see how does having new Democratic leadership affect that. We would believe with Texas' rainy day fund and the funds they have, that maybe we can get some more dollars put into the elderly population, elderly and disabled population, but we'll see. All things being told, we think it's probably a little easier environment after the recent elections than maybe we faced before.

Raj Kumar
Healthcare Services Analyst, Stephens

Got it. When I kind of think about Addus, it is like there is this value proposition of having these three levels of care, and you do not really see that, at least amongst other public companies that have personal care, home health, and hospice, at least to the scale that you guys have built up. I guess, what is the clearest evidence of having that three-service model, in terms of the benefit that you guys see across maybe cross-referrals? Clearly you have highlighted the bridge program with home health and hospice, but as I kind of think about longer term value to the payers in terms of value-based care, what is something that where you stand out more, when you even kind of do point-of-sale solutions relative to someone that is just a single-service operator?

Dirk Allison
Chairman and CEO, Addus HomeCare

Everybody thinks about it differently. I am talking about the provider, think of their business. We have always taken the approach that personal care is the one service that is in the elderly home the most. Where in home health, you might be in once a week, once every two weeks, depending on the plan of care. Certainly hospice is a different environment. But if you think of personal care, we are in there anywhere from three to five times a week. We are in there from two hours to four hours. We see this elderly patient every day, and we should be the first line of defense that sees if there are changes of condition. If you start thinking in terms of your payers, the payers' issue is these are a very high-cost member.

The elderly population, we are talking 75 years above, they are the ones that tend to go to the emergency room, readmits to the hospital. They are the ones that have difficulty getting to their PCP to have flu shots, other aspects taken care of, the kind of preventative measures to keep them from the higher-cost care. What we have been able to work with our payers on is, we can use the non-clinical base as a start, supplemented by the clinical services we are able to bring over to the top of that, to try to help them with value-based care. We have had a number of programs over the last few years that have proven, especially around two or three areas, readmits to hospitals after surgery, emergency room visits that can be avoided. There are certain emergency rooms you cannot, but some you can. Then closing care gaps.

Like I said, the flu shots and the other things that might lead to hospitalizations if these patients are not able to access that particular kind of care. We have been able to work with our payers to show them value with that. Our belief is that all starts with personal care.

Raj Kumar
Healthcare Services Analyst, Stephens

Yeah.

Dirk Allison
Chairman and CEO, Addus HomeCare

We're the ones there that see them so often, then we can move up the ladder to help the payers. It's proven to be very effective. We have programs going in New Mexico. We have them going in Texas. We have them going in Illinois. We're pretty excited about that future, and we're continuing to talk to our payers about how we can do more with them along those lines.

Raj Kumar
Healthcare Services Analyst, Stephens

Got it. As I kind of think about maybe personal care and home health as those two conjoined services, I know you guys used to run, or maybe are still running, a pilot in New Mexico with Presbyterian, around kind of bundling those offerings. I guess, when we think about, clearly they require scale on both sides as a standalone from personal care and home health. You have the personal care scale, you're trying to build out the home health scale. As we kind of think about what scale is required on the home health side to be able to wrap around those services together, maybe kind of help us kind of think about what that path looks like.

As we think about maybe the bridge program is like a proxy, like you get 25% of your referrals from your own home health business. What would it take to get to something similar where you're also serving the home health benefit of that same patient?

Dirk Allison
Chairman and CEO, Addus HomeCare

Yeah. One of the things we're doing, we have this huge population base of, what, 65,000 elderly individuals that have various healthcare needs. We've been focusing, as you've said, on the bridge program between home health and hospice. We're up to about 30% now in our own admissions into hospice when we have overlapping home health in that market. What we have found as it relates to the value-based care is, if you start with PCS, you don't necessarily have to have a full-blown home health on top of that just for this value-based care. You can have clinical assets, whether it's RNs, different folks that you can draw on that can work on value-based care. Our long-term approach is this.

If we can take this large population of non-clinical care and start using technology to help them understand and help us understand, whether it is the payers, whether it is the patients and their families, or whether it is us, when are they getting close to needing other segments of care up the line? That is very important to us, and it is a bridge program that does not start with home health. It starts with personal care.

To do that, we need technology that is the same all the way across, which leads to the fact that we are in the middle of a process of moving all of our personal care systems over to Homecare Homebase. Once that is completed, then we believe we should be able to see a lot of benefits of moving up the level of care with these patients that start from a non-clinical basis.

Raj Kumar
Healthcare Services Analyst, Stephens

Got it. Got it. Yeah, maybe let us kind of focus in on personal care, the biggest kind of operating division within Addus. Heading into 2027, I think you framed organic growth within the long term 3%-5% as what kind of Illinois is kind of bypassing the rate for next year, although we will know if it comes back for 2028. But on the volume side, clearly billable hours growth from a same-store perspective as well has kind of been in that 2%-2.5% range that you guys target, largely driven by just maximizing the fill rate in the kind of mid-80s.

I guess as you kind of think about the fill rate component, I think you guys target maybe upper 80% fill rate. What are the functions to kind of get in there? Is it largely staffing driven still more, or just existing staff engagement through the caregiver app that you have rolled out?

Brian Poff
EVP and CFO, Addus HomeCare

Yeah, I think the way we look at it, getting up into the mid-80% range, we were probably low 80s kind of pre-COVID. That dropped down into the 70s, and we have seen some rebound. But I think part of the push that we have made to kind of get into this range and where we will continue to go is really kind of through the technology side. Think about our business, a lot of it is logistics-based, right? So it is just scheduling efficiency, using our caregivers, making sure their availability matches up with where we have clients and have authorized hours and needs.

The app that we've developed that we pushed out now in Illinois, now in Texas, and to a certain extent in New Mexico, we've seen the benefits of that, where we can actually push out to caregivers the opportunity to take extra shifts, adjust their schedule, update their preferences to maximize the number of hours that they're working. By and large, our caregivers want more hours, so it's helpful for them as well. We've seen in those instances, Illinois was the first market that we rolled out the app. We saw that move up into that upper 80% range over a period of time. We rolled it out in Texas earlier this year. We've seen really nice response in our fill rate in Texas as a result. I think the way we're looking at it's going to be primarily technology-based.

I think some of the things we're doing in Homecare Homebase as well as we roll more and more states into that system, some of the things that we built into that system from a scheduling perspective should help also with efficiency of scheduling. I think our expectation would be, can we get the mid-80% range up into that upper 80% range over the next 12- 18 months? We think that's probably a reasonable target for us.

Raj Kumar
Healthcare Services Analyst, Stephens

Got it. I guess on the staffing component, just kind of with PCS and it being kind of non-skilled in nature, clearly hourly workforce, you're competing with kind of other nodes that are also kind of more minimum wage oriented. As we kind of think about that, with Medicaid work requirements, large or potentially seen as a tailwind, but you've called out Montana, you're not really seeing any aggregate pickup in, say, work volumes from existing Medicaid patients who are required to kind of meet those eligibility standards. So, kind of how do we think about kind of staffing and ability to kind of continue that pace?

I know you guys have initiatives around turnaround in terms of onboarding to make it more efficient, but what inning would you say those initiatives are on as we kind of think about clearly the demand side of the equation's there, and kind of how does supply catch up to it?

Dirk Allison
Chairman and CEO, Addus HomeCare

Yeah, I'd say we're probably in the mid-innings. We started this 18 months, two years ago, trying to make it easier for people to apply, because if you think in terms of our caregiver, they work an average of 22 hours a week. A lot of them want more hours than that, so they may actually work for more than one agency at a time, because the limitation we have is the overtime. If we go into an overtime with an individual, we lose money on every hour above, so we have to be very careful. So, they've learned to piecemeal that. So, what it really means is when someone applies with us, we need to give them hours quickly. We need to get them to work because that's what they're looking on.

Then we need to give them the ability to try to get as many hours as they want, as easily as they want, without going into overtime, which is what the Addus Connect system is all about, is trying to do that. So, for us, growth, that growth in hours is going to be key to who we can hire. When you're talking an industry like personal care, the industry itself probably averages 65% turnover. We average 50%. That's a lot of turnover. It's probably the best we've been in a long time, but we have to hire a lot of people to meet up with the demand. So, that's why we spent so much time on trying to make the applying and getting to the first hour of care convenient and easy.

Raj Kumar
Healthcare Services Analyst, Stephens

Yep.

Dirk Allison
Chairman and CEO, Addus HomeCare

So for us, we need that 103 or 104- 110 hires per business day. We need to stay in that area right now at our size, to be able to meet those needs. Some months you're going to be a little below that. If you have a couple holidays in the month, people aren't looking for jobs at that time, you might drop a little bit. But on a quarterly basis, we've been pretty consistent in staying in that target. That's really what our team focuses on, is we have got to hire people. We got to figure out the reasons. If we're not getting them hired, why? And take care of that, because our limitation to growth is not as much on the side of not having an elderly population to serve. It's more in most markets having the caregivers to serve those in need.

Raj Kumar
Healthcare Services Analyst, Stephens

Yep. Got it. Then kind of the second driver of volume, census. Clearly it's been a focus for investors as we kind of think about same store census. I think Illinois and Texas are still kind of seeing, at least in the month of September, some softness relative to kind of earlier in the quarter. But you called out similar trends relative to the first half or third quarter. So, maybe kind of as we think about, there's some distinctions, targeting higher hour clients or, yeah. And then, maybe competitively, because it seems like Illinois and Texas might also have providers that are similar or similarly scaled or partially scaled to an aspect that, is there a competitive component to census that maybe that's kind of driving maybe neutral wings?

Dirk Allison
Chairman and CEO, Addus HomeCare

I think in Illinois over the last couple years, because it is a market that has gone from being one people question the financial viability of the state, at least in our industry, to being one of the better states for the service that we operate. I think there have been some new folks come into the market. But most folks that are new come in the market, they are not competing with us on size. They are very small. Maybe they have got 10, 15, 20 patients, but those are 10 or 20 patients we might have gotten before.

We have to do a job of making sure we are out in the community talking about getting these individual new folks on service. We also have started talking a little bit, just so people understand, and Brian and I have tried to figure what is the right way to talk about it, but generally our standard patient has 50-70 hours a month service. Those are the ones that really fit into your ability to take a caregiver and give them the hours they need. In the past, we have had a number of clients under 10 hours a month that are really respite patients, and those are the ones we are not trying to move away from them per se, but we are trying to make sure that we are getting the new clients that are easier for our caregivers to be able to get the hours they need.

That is where, when we look at it, census itself does not tell us the story that I think some of the shareholders want to see. I think looking at that hourly census, the higher hour census, you definitely need to bring those on. And we need to continue to service some of the lower hour censuses where there is need, but focus more of our efforts on the other level. And that is what we have done. We are getting closer and closer to that annual tip over where we are actually showing positive census growth. So we will get there. The team is very focused on that. But all that being said, again, for us, while census is a key, we believe taking hours and driving to the authorized hour.

We are not trying to actually go back to the state and say, "You are giving us 70 hours, we need 80 hours." We are saying to them, "You have given us 70 hours and we are only working 56 of those hours. How do we get another four or five hours out of that appropriately to take care of that patient?" And that has been our focus really the last, what, three years with Addus Connect.

Raj Kumar
Healthcare Services Analyst, Stephens

Got it. Maybe kind of framing, I guess, 4Q census trends in terms of, you've given us kind of how October has gone. Maybe as we kind of look at pre-COVID, before Medicaid terminations and all those types of dynamics, how have November and December trended from a census perspective, pre-COVID as we kind of think about expectations for census for 4Q overall?

Dirk Allison
Chairman and CEO, Addus HomeCare

The months of November and December, you're probably not going to grow census like you do other months, but year-over-year they're the same. The reason being you've got Thanksgiving in November, you've got Christmas, and then really the start of New Year's in December. Realistically, that's where even the states themselves probably don't do. They're not going out and getting authorized hours for new patients quite as quickly. So, the census should still grow. Our hope is to grow year-over-year. If you look each month during the fourth quarter, you're probably going to see November and December just be slightly lower only because of that aspect. It's not because the service is any less important. For us as a team though, we've spent the last 11 years talking to our team about holidays, you still need to take care of the patient.

If they don't want you in your home on the holiday, can we work around the holiday? So, existing patients are still very important, and that's what drives hours. It's the new patients that we don't control when the state approves those that maybe we get in the holiday times, we get a little less than what we would normally get in other quarters.

Raj Kumar
Healthcare Services Analyst, Stephens

Got it. Maybe just one last one on personal care before we move on. Clearly managed care is a big component in terms of reimbursement with New Mexico. The dollars are distributed by managed care organizations. As we kind of think about that relationship and your ability to kind of scale these services, and be the partner of choice, maybe just kind of walk us through some of the rate dynamics and whether it's more specifically linked to access to your caregiver supply or even fill rates, and then whether they're more also intentionally looking at, say, hospitalization rates, something that you touched on earlier in the conversation.

Brian Poff
EVP and CFO, Addus HomeCare

Yeah, I think particularly in New Mexico, where we do have the opportunity to negotiate rates directly with the MCOs, I think the primary factor for them, and really kind of really far our thesis all along has been really just more coverage and density. If you are a large plan in New Mexico, you have a big client base out there that needs services, I think they would prefer to work with firms like ourselves that literally can cover wherever their constituents may live, not just in kind of pocketed areas. I think that is probably the first key. Then I think quality and performance is important to them as well. They want to make sure that we are adherence to the EVV mandates, we are actually providing the care, our caregivers are showing up consistently, they do not have complaints from family members. That is important to them.

I think it is less so kind of access to caregiver population and things like that. We are all out there recruiting at a very similar level, but I think those are probably the two primary components that they look to when they deal with us. Then I think, additionally, we deal a lot with those folks in New Mexico on the ground, but certainly the folks that deal in New Mexico also are national MCOs as well, and we have relationships at the national level, and I think that is helpful for us in kind of those conversations.

Raj Kumar
Healthcare Services Analyst, Stephens

Got it. Hospice has kind of, throughout the last couple years, has kind of been one of the strong suits, high single-digit organic growth, mainly recovering from the kind of pandemic era, pull forward in moratoria. As we kind of think about that business segment, how do you kind of balance growth and margin? As we kind of think about operating margins, I think they are slightly down year-over-year. I know there has been a kind of rebuilding of the entire management team for that segment. So, maybe just highlight kind of the opportunities still available in hospice. I know from an M&A perspective, it might still be a little too hot from a multiple perspective, but as we kind of think about even de novos post CMS's moratoria, how should we kind of think about the build-out of that segment?

Brian Poff
EVP and CFO, Addus HomeCare

Yeah, I think in hospice, we consistently get 2%-3% rate increase out of CMS. That has been pretty consistent the last several years. So, we expect to see that continue. Nothing that we see today would indicate that there is going to be probably any real change there. I think our sales teams have done a really good job about they are really targeting the right referral sources, the right partners for us in that regard, and really growing just our ADC. We have seen nice consistent growth in that area year-over-year, quarter-over-quarter. We sit here today, I think we talked about it recently, we are over 4,100 ADC. So we are a pretty sizable provider in that space.

I think just on the margin profile, I think the key for us in hospice is always going to be staffing efficiency, is always going to be important, on how many nurses do you have kind of per client, making sure you're being efficient in that regard. That's something that we'll always kind of focus on. But I think we're pretty pleased with kind of the current trajectory of our hospice business. I think on the M&A side, yeah, things have been very expensive the last few years, so we haven't done a deal.

In pure play hospice, we've gotten a little bit of hospice and some other mixed assets over the last couple years. It feels to us that maybe those multiples are starting to rationalize a little bit. I think if they come down into a range that would make more sense for us, I think those would be opportunities for us to maybe look at some things in that space.

Raj Kumar
Healthcare Services Analyst, Stephens

Got it. Maybe, can you remind us kind of what you kind of look to target between small, medium, and large assets from a multiple perspective?

Brian Poff
EVP and CFO, Addus HomeCare

Yeah, I can talk more broadly just about all segments that we want. I think on the personal care side, in our view, small assets continue to be probably 4x-5x. If they're a little more sizable, could be upper single digits. Look at the two big deals we did, Gentiva and AccentCare, both probably very low double-digit range, pre-synergy. I think on the home health side, and we think there could be more opportunities in that space next year with some of the stabilization and reimbursement. But we would look at typically home health, smaller side are going to be single-digit multiples. If it's more sizable, really good quality, could that start to press close to double digits? Yeah, that's probably fair.

Hospice traditionally, pure play, decent size have been more mid-teen expectation, which are a little above probably what is comfortable for us. More recent deals we have seen have come down into what look like lower double-digit range. There are opportunities there. That could make some sense for us. If there are smaller deals that maybe could slip into single digits, we would definitely be interested in those.

Raj Kumar
Healthcare Services Analyst, Stephens

Got it. I guess kind of thinking about hospice and kind of if we kind of thinking about if we are still in the maybe late innings of the recovery trend or if the ballgame is kind of finished from that perspective. Admissions pretty stable, length of stay is above 100. I guess kind of, have we kind of reached kind of pre-COVID levels? From a referral standpoint, have we reached normalization between hospital and skilled nursing referral mix?

Brian Poff
EVP and CFO, Addus HomeCare

Yeah, I think for the most part, we are back into a definitely more stable environment. I would not say it is probably necessarily quite back to pre-COVID, but I think we are very close. I think we have seen a lot of consistency in our business. I think our discharge length of stay, yeah, is a little over 100. It has been kind of in that range pretty consistently, but I think that is pretty in line with what we see in the industry at large today.

So it is a good spot for us to be. We focus more on kind of median length of stay. We have been kind of in that mid-20-day range. I think if we are there, maybe even upper 20 days, that is kind of a really a good place for us to operate and be, and we have been in that spot pretty consistently the last several quarters.

Raj Kumar
Healthcare Services Analyst, Stephens

All right. Yeah, maybe just moving on to home health now. I guess, inflection towards growth, kind of maybe looking at that path between both margins, which have steadily risen as you kind of right-size that business. As we kind of think about now post-2026, how should we kind of think about the long-term framing? Hospice, mid to high single digits. Home health, it has kind of been in a standby mode in terms of getting the margin profile right before kind of looking for growth. How should we kind of think about that business on a go-forward basis?

Brian Poff
EVP and CFO, Addus HomeCare

Yeah, I think we're going to get, it looks like a 2.4% rate increase nationally. It was put into place and finalized. First time we've seen a nice rate increase, obviously, in the last several years. I think as long as that continues or is consistently kind of in that range, say, kind of like hospice, 2%-3%, we should get some volume growth. I think some of the changes we made in our home health division with leadership earlier this year, and he made some changes in our sales teams and kind of our processes there as well that I think have started to pay some real dividends for us. So, it was very nice for us to post, even before this rate increase that's coming in 2027, we were able to post a same-store increase year-over-year, first time in probably several quarters for us.

All that being said, I think longer term, if all that continues, we would expect to be probably in the mid-single digits overall, would be a fair expectation. It's still a small division for us. We're really only operating in three kind of primary states. If we're able to expand and get some additional leverage in that business over time, maybe through M&A, maybe that can be helpful as well. But that's how I would look at it today.

Raj Kumar
Healthcare Services Analyst, Stephens

Got it. As you kind of think about maybe episodic volumes versus kind of your traditional MA per visit type of reimbursement structures, where are you guys on that front? Are you still working towards kind of having payers go towards episodic? Would just be helpful in kind of that framing as we kind of think about your home health book today.

Brian Poff
EVP and CFO, Addus HomeCare

Yeah, our mix has been pretty consistent. We're a little more slanted toward episodic than per visit. I think our conversations with MA plans, we definitely would prefer episodic. We've had a couple of wins in that regard. Some folks want to still stick to the per visit. We've gotten some better rates there. But I think we've been pretty specific about who we'll work with, what the structure is, what profitability looks like when we're really thinking about which cases we're going to take for our resources. I think we've gotten into a pretty good rhythm. But we really haven't seen, to be honest, a couple years ago, the industry at large saw a pretty big shift, right, in that regard into MA. It's been pretty stable for us for I'd say the last probably year and a half.

Raj Kumar
Healthcare Services Analyst, Stephens

Got it. As we kind of come up on time, maybe just to kind of close out, I guess when investors maybe debate the Addus story, just parts of thinking about Medicaid rate durability, especially with the One Big Beautiful Bill, caregiver availability, which kind of unlocks that demand part of the equation. Just maybe also the kind of differentiated platform and how that ultimately works together. I guess, what do you kind of believe is the most underappreciated aspect of the kind of potential earnings power of this business, say, over the next three to five years?

Dirk Allison
Chairman and CEO, Addus HomeCare

Yeah, I think one of the things is the ability to use technology in a bridge program. We've demonstrated it on 20% of our business, but we got this very large and nice PCS business that we are starting to develop a lot of data on these individuals and the potential of needs down the road that we could serve. I think getting the Homecare Homebase transaction done, which we should be converted, our plan is to be totally converted by the end of 2027, with the exception of now we got AccentCare coming on, which we'll follow after that. But through Texas, which would, the first part of Texas, which would be the Gentiva transaction, hopefully by the end of 2027.

So now all of a sudden you're going to have all this technology and information that you're going to be able to mine data to figure out how do we continue to offer the right services to those folks up the line, whether it be Even in hospice, you can service them with PCS. I think that's one of the real aspects out there. Then the other one, which is people do know about, but it's as we continue to drive our Addus Connect throughout the company, moving our authorized hours served up into that high 80s is going to have real impact on our bottom line. So those are the two things we're really focused on over the next 24- 36 months of getting them done and hopefully seeing the benefits of those.

Raj Kumar
Healthcare Services Analyst, Stephens

All right, perfect. Well, appreciate you guys being here and this great conversation.

Dirk Allison
Chairman and CEO, Addus HomeCare

Thanks, Raj.

Brian Poff
EVP and CFO, Addus HomeCare

Thanks, Raj.

Dirk Allison
Chairman and CEO, Addus HomeCare

Appreciate it.

Brian Poff
EVP and CFO, Addus HomeCare

Appreciate it.